IRIDEX (IRIX) vs SiNtx Technologies (SINT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
IRIDEX (IRIX) has outperformed SiNtx Technologies (SINT) over the past year, losing 17.6% versus a loss of 53.3%. Over five years, IRIX leads with a -87.9% price change compared with -100.0% for SINT. IRIDEX is the larger company by market cap ($15.8 million vs $14.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IRIX | SINT |
|---|---|---|
| Share price | $0.898 | $2.11 |
| Market cap | $15.77M | $14.06M |
| 1-day change | +2.24% | -2.76% |
| YTD return | -21.23% | -45.34% |
| 1-year return | -17.61% | -53.32% |
| 5-year return | -87.88% | -99.99% |
| EPS (TTM) | $-0.20 | $-4.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.65 | $4.64 |
| 52-week low | $0.61 | $1.40 |
| Distance from 52-week high | -45.58% | -54.53% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +206.24% | +338.39% |
| Average volume | 389.24K | 112.93K |
| Shares outstanding | 17.56M | 6.66M |
| Employees | 93 | 32 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRIX has outperformed SINT by 35.7 percentage points over the past year.
About IRIDEX
IRIX stock →IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.
Healthcare · Medical Devices · 93 employees
About SiNtx Technologies
SINT stock →Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE).
Healthcare · Medical Devices · 32 employees
IRIX vs SINT FAQ
Which is bigger, IRIDEX or SiNtx Technologies?
IRIDEX (IRIX) is larger, with a market capitalization of $15.77M compared with $14.06M for SiNtx Technologies (SINT).
Which stock has performed better over the past year, IRIX or SINT?
IRIX returned -17.61% over the past 12 months, compared with -53.32% for SINT (price return, excluding dividends). Past performance does not predict future results.
Are IRIDEX and SiNtx Technologies in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.